Загрузка...
Systemic complement activation levels in Stargardt disease
PURPOSE: Preclinical research provides evidence for the complement system as a potential common pathway in Stargardt disease (STGD1) and age-related macular degeneration (AMD) leading to retinal pigment epithelium (RPE) loss. However, systemic complement activation has not yet been assessed in STGD1...
Сохранить в:
| Опубликовано в: : | PLoS One |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Public Library of Science
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8232401/ https://ncbi.nlm.nih.gov/pubmed/34170959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0253716 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|